Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by scarlet1967on Jun 26, 2022 4:09pm
141 Views
Post# 34783312

RE:RE:RE:Excess of adipose visceral fat causing NAFLD regardless of..

RE:RE:RE:Excess of adipose visceral fat causing NAFLD regardless of..The best preventative measure against obesity is life style changes, more exercise, better diet etc. but the reality is most people mentally are not capable of making those changes. For instance try to tell a smoker the risks and quit. I don't think it is impossible to change but it takes a lot of motivation and strength and unfortunately it's harder than what can imagine to make those life saving changes. That's just the ugly reality of the whole thing.

PWIB123 wrote: Can you all help a scientific lay person like me understand why a patient with obesity would utilize Egrifta versus simply any other very common form of weight loss measures?  Is it that when you get to the point of NAFLD or NASH that those no longer work and you need a drug like Egrifta?  It seems to me that you could reverse the effects of NAFLD or NASH simply by losing weight.  I'm trying to understand where Egrifta becomes necessary.  Thanks in advance.


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse